
ChitogenX ( ($TSE:CHGX) ) has shared an announcement. ChitogenX Inc. has entered into a binding letter of intent with Oligo Medic Inc. to pursue a potential reverse takeover transaction, aiming
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CHNXF | ChitogenX | 0.01 | 0.00 | 0.00% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.01 | 0.00% |

ChitogenX ( ($TSE:CHGX) ) has shared an announcement. ChitogenX Inc. has entered into a binding letter of intent with Oligo Medic Inc. to pursue a potential reverse takeover transaction, aiming

ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc. reported a reduced net loss of $0.6 million for the third quarter of 2025, marking a 23% improvement from the previous year.

ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a clinical-stage regenerative medicine company, has reported a decrease in net loss and a significant reduction in research and development (R&D) as

ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a pioneering firm in regenerative medicine, has concluded its virtual Annual General Meeting, successfully re-electing six director nominees and appointing Audacie Inc.

ChitogenX (TSE:CHGX) has released an update. ChitogenX, a clinical-stage regenerative medicine company, has reported a marginal Q1 2025 loss of $0.2 million, a notable improvement from the previous year, alongside

ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a clinical-stage regenerative medicine company, has reported significant strides in its fiscal year 2024, including the advancement of a new skin repair

Chitogenx Inc. (TSE:CHGX) has released an update. ChitogenX Inc., a company specializing in regenerative medicine, has announced the departure of their CEO, Philippe Deschamps, and his resignation from the Board
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.